AI Signal & Stock Analysis · Strong ↑
As of Nov 13 2026, 8:10 AM, AkshayaAI's signal for GMAB is Strong ↑; the stock is at $50.85 (-1.73% today); neutral (RSI 58); technical trend is Raise; news sentiment is positive. What changed: the signal moved from Very Strong to Strong on 13 Nov 2026; the technical trend turned Raise (was down-trend) on 13 Nov 2026.
Data as of Nov 13 2026, 8:10 AM. Informational analytics only — not investment advice.
Instant, data-backed answers — free to try.
| AI signal (Strength) | Strong ↑ |
|---|---|
| Price | $50.85 |
| Change today | -1.73% |
| RSI (14) | 57.69 |
| Relative volume | 1.15 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $31.3B |
| Forward P/E | 31.28 |
| 52-week high | -15.1% away |
| 52-week low | +115.5% above |
| Technical trend | RAISE-2026-09-15 |
| News sentiment | Positive |
| Sector | Healthcare-Biotech |
| Next earnings | 11/5/2026 4:30:00 PM |
As of Nov 13 2026, 8:10 AM, AkshayaAI assigns GMAB (Genmab ADR) a Strong signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
GMAB's RSI is neutral (RSI 58). A reading above 70 is typically considered overbought and below 30 oversold.
GMAB is trading about 15% below its 52-week high and 116% above its 52-week low as of Nov 13 2026, 8:10 AM.
GMAB's next earnings date is 11/5/2026 4:30:00 PM.
GMAB is classified under Healthcare-Biotech in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for GMAB — not personalised investment advice. Always do your own research.
VRTX · REGN · ARGX · ONC · RPRX · RVMD
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Nov 13 2026, 8:10 AM and may not reflect real-time prices. Always do your own research. How these signals work →